Stock Comparison
JNJ vs NVO
Johnson & Johnson and Novo Nordisk A/S side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$613.02B
$212.80B
P/E (TTM)
29.5
11.6
Forward P/E
22.0
14.3
Price/Sales
6.4
0.7
Price/Book
7.6
6.9
EV/EBITDA
19.2
8.5
Dividend Yield
2.12%
3.75%
Profitability
Net Margin
21.80%
37.20%
Operating Margin
27.40%
61.60%
Return on Equity
26.40%
71.40%
Return on Assets
8.42%
19.30%
Growth (YoY)
Revenue Growth
9.90%
24.00%
Earnings Growth
-52.90%
67.10%
Price & Risk
Beta
0.3
0.3
52-Week High
$255.11
$68.49
52-Week Low
$147.81
$34.58
Analyst Target
$257.32
$46.86
Compare JNJ and NVO your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.